US equities |
META $620.19 ▼-1.64% MU $928.76 ▲+2.77% TSLA $407.46 ▲+4.04% NVDA $217.94 ▲+0.90% SPCX $148.58 ▲+1.14% AAPL $347.10 ▲+0.93% AMD $560.26 ▲+5.45% MSFT $531.33 ▼-0.24%
FinancialContent

Curanex Pharmaceuticals Inc - Common Stock (NQ:CURX)

4.765 +0.165 (+3.58%)
Delayed Quote Updated: 12:18 PM EDT, Oct 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Curanex Pharmaceuticals Inc - Common Stock

News headline image
CURX Investors Have Opportunity to Join Curanex Pharmaceuticals Inc Fraud Investigation with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – CURX
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation – CURX
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Stocks in the News: ALBT, NDRA, CURX, HCTI – AI, Clinical Milestones Drive Market Surges
Via AB Newswire
Topics Artificial Intelligence
News headline image
Curanex Pharmaceuticals (CURX): An Emerging Force in US Botanical Drug Development
Via Get News